Common Contracts

OMNIBUS THIRTEENTH AMENDMENT TO CREDIT AGREEMENT AND FIFTEENTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT

Credit Agreement • March 25th, 2015 • Implant Sciences Corp • Measuring & controlling devices, nec • New York

• Contract Type
  Credit Agreement
• Filed
  March 25th, 2015
• Company
  Implant Sciences Corp
• Industry
  Measuring & controlling devices, nec
• Jurisdiction
  New York

This Omnibus Thirteenth Amendment to Credit Agreement and Fifteenth Amendment to Note and Warrant Purchase Agreement (“Amendment”) is made as of the 19th day of March, 2015 between Implant Sciences Corporation, a Massachusetts corporation (the “Company”), and DMRJ Group LLC, a Delaware limited liability company (the “Investor”).

OMNIBUS TWELFTH AMENDMENT TO CREDIT AGREEMENT AND FOURTEENTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT

Credit Agreement • March 26th, 2014 • Implant Sciences Corp • Measuring & controlling devices, nec • New York

• Contract Type
  Credit Agreement
• Filed
  March 26th, 2014
• Company
  Implant Sciences Corp
• Industry
  Measuring & controlling devices, nec
• Jurisdiction
  New York

This Omnibus Twelfth Amendment to Credit Agreement and Fourteenth Amendment to Note and Warrant Purchase Agreement (“Amendment”) is made as of the 19th day of March, 2014 between Implant Sciences Corporation, a Massachusetts corporation (the “Company”), and DMRJ Group LLC, a Delaware limited liability company (the “Investor”).

OMNIBUS ELEVENTH AMENDMENT TO CREDIT AGREEMENT AND THIRTEENTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT

Credit Agreement • November 18th, 2013 • Implant Sciences Corp • Measuring & controlling devices, nec • New York

• Contract Type
  Credit Agreement
• Filed
  November 18th, 2013
• Company
  Implant Sciences Corp
• Industry
  Measuring & controlling devices, nec
• Jurisdiction
  New York

This Omnibus Eleventh Amendment to Credit Agreement and Thirteenth Amendment to Note and Warrant Purchase Agreement (“Amendment”) is made as of the 14th day of November, 2013 between Implant Sciences Corporation, a Massachusetts corporation (the “Company”), and DMRJ Group LLC, a Delaware limited liability company (the “Lender” or “Investor”).